Eric Bergren is named as a lobbyist on federal disclosure filings for 67 clients through Todd Strategy Group. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Medicare/Medicaid, Pharmacy and Copyright/Patent/Trademark.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| PERSONALIS, INC. | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Pharmacy |
| INFLAMMATIX, INC. | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid |
| INOVIO PHARMACEUTICALS | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| FREENOME | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues |
| U.S. CHAMBER OF COMMERCE GLOBAL INNOVATION POLICY CENTER | TODD STRATEGY GROUP | Q3 2026 | Copyright/Patent/Trademark |
| OTSUKA AMERICA PHARMACEUTICAL, INC. | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| EXELIXIS, INC. | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues, Copyright/Patent/Trademark |
| ELI LILLY AND COMPANY | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues, Pharmacy |
| ASTELLAS PHARMA US, INC. | TODD STRATEGY GROUP | Q3 2026 | Copyright/Patent/Trademark, Pharmacy, Health Issues |
| AMERICAN MEDICAL ASSOCIATION | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues, Pharmacy |
| MYRIAD GENETICS, INC. | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid |
| GLAXOSMITHKLINE LLC | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues |
| GENMAB | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues |
| FOX CORPORATION | TODD STRATEGY GROUP | Q3 2026 | Telecommunications, Communications/Broadcasting/Radio/TV, Taxation/Internal Revenue Code |
| NOVO NORDISK INC. | TODD STRATEGY GROUP | Q3 2026 | Pharmacy, Health Issues |
| DELFI DIAGNOSTICS | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Pharmacy, Health Issues |
| SOUTHWEST TRANSPLANT ALLIANCE | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| COMPASS PATHWAYS INC. | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| AMERICAN SOCIETY OF NEPHROLOGY | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| ALKERMES, INC. | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues |
| ASTRAZENECA PHARMACEUTICALS LP | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues, Tariff (miscellaneous tariff bills) |
| AMGEN INC. | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code |
| SUNBOUND HOMES | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid |
| GILEAD SCIENCES, INC. | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| BRISTOL-MYERS SQUIBB COMPANY | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues, Pharmacy |
| BIOGEN, INC. | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid, Health Issues, Pharmacy |
| VANTIVE US HEALTHCARE LLC | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| VALISURE | TODD STRATEGY GROUP | Q3 2026 | Pharmacy |
| THE COALITION FOR 21ST CENTURY MEDICINE | TODD STRATEGY GROUP | Q3 2026 | Medicare/Medicaid |
| TAKEDA PHARMACEUTICALS AMERICA, INC. | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Medicare/Medicaid, Health Issues |
| SIDECAR HEALTH | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Medicare/Medicaid |
| NOVARTIS, INC. | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Medicare/Medicaid, Health Issues |
| NCTA - THE INTERNET & TELEVISION ASSOCIATION | TODD STRATEGY GROUP | Q3 2026 | Telecommunications |
| MUTUAL OF OMAHA | TODD STRATEGY GROUP | Q3 2026 | Insurance |
| MEDICAL COUNTERMEASURES COALITION | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| JOHNSON & JOHNSON SERVICES, INC. | TODD STRATEGY GROUP | Q3 2026 | Veterans, Health Issues |
| INSULET CORPORATION | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| CALYXO, INC. | TODD STRATEGY GROUP | Q3 2026 | Health Issues |
| BAYER CORPORATION | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Taxation/Internal Revenue Code, Medicare/Medicaid |
| EMD SERONO INC. | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Pharmacy, Health Issues |
| PMI US CORPORATE SERVICES INC. | TODD STRATEGY GROUP | Q3 2026 | Tobacco, Government Issues, Budget/Appropriations |
| GENENTECH, INC. | TODD STRATEGY GROUP | Q3 2026 | Budget/Appropriations, Medicare/Medicaid, Health Issues |
| APOLLO GLOBAL MANAGEMENT | TODD STRATEGY GROUP | Q3 2026 | Financial Institutions/Investments/Securities |
| ALNYLAM PHARMACEUTICALS, INC. | TODD STRATEGY GROUP | Q3 2026 | Trade (domestic/foreign), Medicare/Medicaid, Pharmacy |
| MERCK & CO., INC. | TODD STRATEGY GROUP | Q2 2026 | Medicare/Medicaid, Health Issues |
| DH DIAGNOSTICS LLC | TODD STRATEGY GROUP | Q1 2026 | Health Issues |
| SIEMENS HEALTHINEERS | TODD STRATEGY GROUP | Q1 2026 | Medicare/Medicaid |
| THE ORTHOFORUM | TODD STRATEGY GROUP | Q2 2026 | Medicare/Medicaid |
| KALDEROS, INC. | TODD STRATEGY GROUP | Q1 2026 | Health Issues |
| GENEOSCOPY, INC. | TODD STRATEGY GROUP | Q1 2026 | Health Issues |
| AMERICAN POLICY VENTURES ACTION | TODD STRATEGY GROUP | Q1 2026 | Economics/Economic Development, Taxation/Internal Revenue Code |
| VIAL HEALTH TECHNOLOGY, INC. | TODD STRATEGY GROUP | Q4 2025 | Health Issues |
| TRUIST FINANCIAL CORPORATION | TODD STRATEGY GROUP | Q4 2025 | Banking |
| FERRING PHARMACEUTICALS INC. | TODD STRATEGY GROUP | Q4 2025 | Health Issues |
| ALLIANCE FOR AMERICA'S PROMISE, INC. | TODD STRATEGY GROUP | Q4 2025 | Veterans |
| ILLUMINA, INC. | TODD STRATEGY GROUP | Q3 2025 | Health Issues |
| ALEXION PHARMACEUTICALS, INC. | TODD STRATEGY GROUP | Q2 2025 | Medicare/Medicaid, Health Issues |
| OSRX PHARMACEUTICALS | TODD STRATEGY GROUP | Q2 2025 | Health Issues |
| FLEXCARE | TODD STRATEGY GROUP | Q1 2025 | Health Issues |
Showing the 60 most recent of 67 engagements.
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 52 | 1 |
| 2025 | 62 | 1 |
| Year | Items | Total |
|---|---|---|
| 2026 | 12 | $7K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Eric Bergren. See the Capitol Clarity rankings and method.